China NT Pharma Group Company Limited (SEHK: 1011)
Health Care · Pharmaceuticals · HK
HK$0.41
+6.49% today · -54.9% 1Y
China NT Pharma Group Company Limited (SEHK: 1011) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $49.58M and employs 32 people.
Over the last twelve months the share price has lost 54.9%, trading between 0.30 and 1.00.
Tweenvest scores China NT Pharma Group Company Limited across four factors: quality 25/100, value 56/100, growth 0/100. Its strongest factor is value.
1011 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $49.58M
- Revenue (TTM)
- $5.27M
- P/E
- —
- EPS
- -0.04
- Dividend yield
- —
- Beta (5Y)
- -1.96
- 52-week high
- HK$1.00
- 52-week low
- HK$0.30
- Avg volume (3M)
- —
- Shares outstanding
- 949.00M
- Employees
- 32
- Next earnings
- —
About China NT Pharma Group Company Limited
China NT Pharma Group Company Limited, operating alongside its various subsidiaries, is dedicated to the full spectrum of pharmaceutical activities. This encompasses the research, development, manufacturing, commercialization, and distribution of medicinal products, serving both the People's Republic of China and international territories. The firm develops and markets prescription medications addressing a diverse array of medical conditions, including oncological and hematological diseases, gastrointestinal disorders, central nervous system afflictions, and respiratory illnesses, among other therapeutic fields. In addition to these specialized drugs, it also produces and distributes its proprietary "NT" branded products and generic formulations. Furthermore, the group extends its offerings to include marketing and promotional assistance for suppliers, alongside providing logistics and consulting solutions. Established in 1995, the company maintains its corporate headquarters in Suzhou, People's Republic of China.
- ISIN
- KYG2114L1133
- Founded
- 1995
- Listed since
- Apr 20, 2011
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Infinium Pharmachem LimitedNSEI: INFINIUM | $50.32M | Rs312.50 | -0.56% |
| Orion Pharma LimitedDSE: ORIONPHARM | $49.78M | Tk26.20 | -9.66% |
| Neurizon Therapeutics LimitedASX: NUZ | $49.76M | AU$0.09 | +15.00% |
| Labiana Health, S.A.BME: LAB | $49.71M | €5.25 | -1.87% |
| Anya Biopharm Inc.TPEX: 7776 | $49.22M | NT$32.05 | -6.56% |
| Haleos Labs LimitedNSEI: HALEOSLABS | $48.85M | Rs1,563.70 | +4.95% |
| GL Pharm Tech Corp.KOSDAQ: A204840 | $48.45M | ₩4,200.00 | -2.78% |
| PharmGen Science, Inc.KOSE: A004720 | $48.11M | ₩2,860.00 | +0.35% |
Figures last refreshed Oct 11, 2026.